Answers are grounded in this paper and cite their sources.
Global health efforts require socially responsible licensing that permits wide-ranging access to inventions that address health challenges beyond the so-called neglected diseases. Our analysis suggests that universities that excel in global health innovation are less likely to have global-access licensing policies in place. This trend can slow access to new clinical products and diminish the ability of universities to address their public missions.
No takes yet. Share an insight, caveat, or question.
Guebert et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: